dapagliflozin 5 MG Oral Tablet

RxCUI: 1488574
RxNorm name: dapagliflozin 5 MG Oral Tablet
Display name: Dapagliflozin (Oral Pill)
Full name: dapagliflozin 5 MG Oral Tablet
Term type: SCD
Status: Active
Strength: 5 mg
Dose form: Tab
Route: Oral Pill
Updated: 2026-08-18 06:18:14

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 032014
Active start: 032014
Multiple ingredient: NO
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
dapagliflozin	5 MG / 1 EACH	dapagliflozin	dapagliflozin

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Oral Tablet	317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
dapagliflozin	1488564

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	dapagliflozin 5 MG Oral Tablet	1	NAMES
RxNorm Name	dapagliflozin 5 MG Oral Tablet	1	NAMES
RxNorm Synonym	dapagliflozin 5 MG Oral Tablet	1	NAMES
TTY	SCD	1	ATTRIBUTES
SPL_SET_ID	21 linked values 3aba33aa-f8c6-4b10-85c8-dfa14578d07c 08baca21-e39e-4e61-961f-d89432fe8007 20a83ea2-6ad8-4bbb-b516-73c0a9e37399 52a778e7-6044-2049-e063-6294a90aa0b7 82cdd5ad-df2b-4bdd-a3a6-a059040100b4 107b4d25-4764-42b7-80e3-9aaff20865ed 0406a1c0-56b1-4ea1-95ae-00357ac1ba7e 828f1004-3647-9a13-8008-c4b3759ecfd0 840e2146-2383-489b-bcc4-fecfe986685a 6425d240-5dd9-4a2c-9348-f8a859702850 8296f538-4c23-4d6c-be53-8005b83c24b7 17586ec6-0104-4b08-ad87-12a837568d6c 91373924-66dc-4277-aaf2-8536e81a0e4d a2f86c0a-ce78-4d06-b5d8-ed457c8e3614 b6b8a10c-64c3-4856-8961-d72d68784f5d bd9766c5-104f-4636-897d-b6c92eb94f18 c4264ff6-5199-49e9-91d3-3ad67b42f88d d44f7eed-dd51-40d1-8408-8fb331e1f1f6 db668c5c-2d49-41c8-8ffd-c2b2652b621a f615d81e-d1e8-4561-a4d9-286c615d3bd2 f56593f7-588e-489d-9fad-b459e90dab18	21	CODES
RxCUI	1488574	1	CODES
MMSL_CODE	2 linked values BD28022 CD28022	2	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
0480-3527-56	0480-3527	DAPAGLIFLOZIN DAPAGLIFLOZIN	Teva Pharmaceuticals, Inc.	ANDA211541
0480-3527-98	0480-3527	DAPAGLIFLOZIN DAPAGLIFLOZIN	Teva Pharmaceuticals, Inc.	ANDA211541
0781-5985-01	0781-5985	Dapagliflozin Dapagliflozin	Sandoz Inc	ANDA211312
0781-5985-05	0781-5985	Dapagliflozin Dapagliflozin	Sandoz Inc	ANDA211312
0781-5985-10	0781-5985	Dapagliflozin Dapagliflozin	Sandoz Inc	ANDA211312
0781-5985-31	0781-5985	Dapagliflozin Dapagliflozin	Sandoz Inc	ANDA211312
27241-151-01	27241-151	Dapagliflozin Dapagliflozin	Ajanta Pharma USA Inc.	ANDA211482
33342-585-07	33342-585	dapagliflozin dapagliflozin	Macleods Pharmaceuticals Limited	ANDA211506
33342-585-10	33342-585	dapagliflozin dapagliflozin	Macleods Pharmaceuticals Limited	ANDA211506
33342-585-12	33342-585	dapagliflozin dapagliflozin	Macleods Pharmaceuticals Limited	ANDA211506
46708-392-30	46708-392	DAPAGLIFLOZIN DAPAGLIFLOZIN	Alembic Pharmaceuticals Limited	ANDA211560
46708-392-91	46708-392	DAPAGLIFLOZIN DAPAGLIFLOZIN	Alembic Pharmaceuticals Limited	ANDA211560
50090-7056-0	50090-7056	DAPAGLIFLOZIN DAPAGLIFLOZIN	A-S Medication Solutions	NDA202293
50090-7971-0	50090-7971	Dapagliflozin Dapagliflozin	A-S Medication Solutions	ANDA211468
59651-159-30	59651-159	Dapagliflozin Dapagliflozin	Aurobindo Pharma Limited	ANDA211468
59651-159-90	59651-159	Dapagliflozin Dapagliflozin	Aurobindo Pharma Limited	ANDA211468
60505-4911-3	60505-4911	Dapagliflozin DAPAGLIFLOZIN	Apotex Corp.	ANDA211523
62332-392-30	62332-392	DAPAGLIFLOZIN DAPAGLIFLOZIN	Alembic Pharmaceuticals Inc.	ANDA211560
62332-392-91	62332-392	DAPAGLIFLOZIN DAPAGLIFLOZIN	Alembic Pharmaceuticals Inc.	ANDA211560
66993-456-30	66993-456	DAPAGLIFLOZIN DAPAGLIFLOZIN	Prasco Laboratories	NDA202293
67877-608-05	67877-608	Dapagliflozin Dapagliflozin	Ascend Laboratories, LLC	ANDA211545
67877-608-30	67877-608	Dapagliflozin Dapagliflozin	Ascend Laboratories, LLC	ANDA211545
67877-608-33	67877-608	Dapagliflozin Dapagliflozin	Ascend Laboratories, LLC	ANDA211545
67877-608-90	67877-608	Dapagliflozin Dapagliflozin	Ascend Laboratories, LLC	ANDA211545
69097-388-02	69097-388	DAPAGLIFLOZIN DAPAGLIFLOZIN	Cipla USA Inc.	ANDA211535
70377-023-11	70377-023	DAPAGLIFLOZIN DAPAGLIFLOZIN	Biocon Pharma Inc.	ANDA211470
70377-023-12	70377-023	DAPAGLIFLOZIN DAPAGLIFLOZIN	Biocon Pharma Inc.	ANDA211470
70710-1380-3	70710-1380	Dapagliflozin Dapagliflozin	Zydus Pharmaceuticals USA Inc.	ANDA211582
70710-1380-9	70710-1380	Dapagliflozin Dapagliflozin	Zydus Pharmaceuticals USA Inc.	ANDA211582
70748-105-06	70748-105	Dapagliflozin Dapagliflozin	Lupin Pharmaceuticals, Inc.	ANDA211531
70771-1714-3	70771-1714	Dapagliflozin Dapagliflozin	Zydus Lifesciences Limited	ANDA211582
70771-1714-9	70771-1714	Dapagliflozin Dapagliflozin	Zydus Lifesciences Limited	ANDA211582
70954-856-10	70954-856	Dapagliflozin Dapagliflozin	ANI Pharmaceuticals, Inc.	ANDA211156
71921-420-09	71921-420	DAPAGLIFLOZIN Dapagliflozin	Florida Pharmaceutical Products, LLC	ANDA211156
71921-420-33	71921-420	DAPAGLIFLOZIN Dapagliflozin	Florida Pharmaceutical Products, LLC	ANDA211156
71921-420-50	71921-420	DAPAGLIFLOZIN Dapagliflozin	Florida Pharmaceutical Products, LLC	ANDA211156
72205-432-01	72205-432	Dapagliflozin Dapagliflozin	Novadoz Pharmaceuticals LLC	ANDA211478
72205-432-02	72205-432	Dapagliflozin Dapagliflozin	Novadoz Pharmaceuticals LLC	ANDA211478
72205-432-03	72205-432	Dapagliflozin Dapagliflozin	Novadoz Pharmaceuticals LLC	ANDA211478
73190-072-30	73190-072	Dapagliflozin Dapagliflozin	AvKARE	ANDA211478
73190-072-90	73190-072	Dapagliflozin Dapagliflozin	AvKARE	ANDA211478

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
ANDA211541	0480-3527	DAPAGLIFLOZIN DAPAGLIFLOZIN	ANDA	Teva Pharmaceuticals, Inc.
ANDA211312	0781-5985	Dapagliflozin Dapagliflozin	ANDA	Sandoz Inc
ANDA211482	27241-151	Dapagliflozin Dapagliflozin	ANDA	Ajanta Pharma USA Inc.
ANDA211506	33342-585	dapagliflozin dapagliflozin	ANDA	Macleods Pharmaceuticals Limited
ANDA211560	46708-392	DAPAGLIFLOZIN DAPAGLIFLOZIN	ANDA	Alembic Pharmaceuticals Limited
NDA202293	50090-7056	DAPAGLIFLOZIN DAPAGLIFLOZIN	NDA AUTHORIZED GENERIC	A-S Medication Solutions
ANDA211468	50090-7971	Dapagliflozin Dapagliflozin	ANDA	A-S Medication Solutions
ANDA211523	60505-4911	Dapagliflozin DAPAGLIFLOZIN	ANDA	Apotex Corp.
ANDA211545	67877-608	Dapagliflozin Dapagliflozin	ANDA	Ascend Laboratories, LLC
ANDA211535	69097-388	DAPAGLIFLOZIN DAPAGLIFLOZIN	ANDA	Cipla USA Inc.
ANDA211470	70377-023	DAPAGLIFLOZIN DAPAGLIFLOZIN	ANDA	Biocon Pharma Inc.
ANDA211582	70710-1380	Dapagliflozin Dapagliflozin	ANDA	Zydus Pharmaceuticals USA Inc.
ANDA211531	70748-105	Dapagliflozin Dapagliflozin	ANDA	Lupin Pharmaceuticals, Inc.
ANDA211156	70954-856	Dapagliflozin Dapagliflozin	ANDA	ANI Pharmaceuticals, Inc.
ANDA211478	72205-432	Dapagliflozin Dapagliflozin	ANDA	Novadoz Pharmaceuticals LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 45 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00480352705	rxnav_ndcs	yes
00480352756	rxnav_ndcs	yes
00480352798	rxnav_ndcs	yes
00781598501	rxnav_ndcs	yes
00781598505	rxnav_ndcs	yes
00781598510	rxnav_ndcs	yes
00781598531	rxnav_ndcs	yes
27241015101	rxnav_ndcs	yes
33342058507	rxnav_ndcs	yes
33342058510	rxnav_ndcs	yes
33342058512	rxnav_ndcs	yes
33342058566	rxnav_ndcs	yes
46708039230	rxnav_ndcs	yes
46708039290	rxnav_ndcs	yes
46708039291	rxnav_ndcs	yes
50090705600	rxnav_ndcs	yes
50090797100	rxnav_ndcs	yes
59651015930	rxnav_ndcs	yes
59651015990	rxnav_ndcs	yes
60505491103	rxnav_ndcs	yes
62332039230	rxnav_ndcs	yes
62332039290	rxnav_ndcs	yes
62332039291	rxnav_ndcs	yes
66993045630	rxnav_ndcs	yes
67877060805	rxnav_ndcs	yes
67877060830	rxnav_ndcs	yes
67877060833	rxnav_ndcs	yes
67877060890	rxnav_ndcs	yes
69097038802	rxnav_ndcs	yes
70377002311	rxnav_ndcs	yes
70377002312	rxnav_ndcs	yes
70710138003	rxnav_ndcs	yes
70710138009	rxnav_ndcs	yes
70748010506	rxnav_ndcs	yes
70771171403	rxnav_ndcs	yes
70771171409	rxnav_ndcs	yes
70954085610	rxnav_ndcs	yes
71921042009	rxnav_ndcs	yes
71921042033	rxnav_ndcs	yes
71921042050	rxnav_ndcs	yes
72205043201	rxnav_ndcs	yes
72205043202	rxnav_ndcs	yes
72205043203	rxnav_ndcs	yes
73190007230	rxnav_ndcs	yes
73190007290	rxnav_ndcs	yes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 24 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Dapagliflozin	DAPAGLIFLOZIN	Sandoz Inc	8296f538-4c23-4d6c-be53-8005b83c24b7	2026-07-30	Warnings, Adverse reactions	Exact identifier ndc (package): 0781-5985-05 ndc (package): 0781-5985-10 ndc (package): 0781-5985-01 ndc (package): 0781-5985-31 ndc (product): 0781-5985 ndc11 (package): 00781598505 ndc11 (package): 00781598531 ndc11 (package): 00781598510 ndc11 (package): 00781598501
Dapagliflozin	DAPAGLIFLOZIN	Aurobindo Pharma Limited	f56593f7-588e-489d-9fad-b459e90dab18	2026-07-17	Warnings, Adverse reactions	Exact identifier ndc (package): 59651-159-90 ndc (package): 59651-159-30 ndc (product): 59651-159 ndc11 (package): 59651015930 ndc11 (package): 59651015990 rxcui: 1488574
FARXIGA	DAPAGLIFLOZIN	A-S Medication Solutions	01f90c94-71cb-4a1f-81ff-8004b850529b	2026-07-10	Warnings, Adverse reactions	Exact identifier rxcui: 1488574
dapagliflozin	DAPAGLIFLOZIN	Macleods Pharmaceuticals Limited	91373924-66dc-4277-aaf2-8536e81a0e4d	2026-07-09	Warnings, Adverse reactions	Exact identifier ndc (package): 33342-585-12 ndc (package): 33342-585-10 ndc (package): 33342-585-07 ndc (product): 33342-585 ndc11 (package): 33342058512 ndc11 (package): 33342058507 ndc11 (package): 33342058510 ndc11 (package): 33342058566 rxcui: 1488574
DAPAGLIFLOZIN	DAPAGLIFLOZIN	Florida Pharmaceutical Products, LLC	20a83ea2-6ad8-4bbb-b516-73c0a9e37399	2026-07-02	Warnings, Adverse reactions	Exact identifier ndc (package): 71921-420-09 ndc (package): 71921-420-50 ndc (package): 71921-420-33 ndc (product): 71921-420 ndc11 (package): 71921042050 ndc11 (package): 71921042033 ndc11 (package): 71921042009 rxcui: 1488574
Dapagliflozin	DAPAGLIFLOZIN	ANI Pharmaceuticals, Inc.	6425d240-5dd9-4a2c-9348-f8a859702850	2026-06-29	Warnings, Adverse reactions	Exact identifier ndc (package): 70954-856-10 ndc (product): 70954-856 ndc11 (package): 70954085610 rxcui: 1488574
Dapagliflozin	DAPAGLIFLOZIN	Ascend Laboratories, LLC	b6b8a10c-64c3-4856-8961-d72d68784f5d	2026-06-25	Warnings, Adverse reactions	Exact identifier ndc (package): 67877-608-33 ndc (package): 67877-608-30 ndc (package): 67877-608-05 ndc (package): 67877-608-90 ndc (product): 67877-608 ndc11 (package): 67877060830 ndc11 (package): 67877060890 ndc11 (package): 67877060805 ndc11 (package): 67877060833 rxcui: 1488574
DAPAGLIFLOZIN	DAPAGLIFLOZIN	Alembic Pharmaceuticals Inc.	840e2146-2383-489b-bcc4-fecfe986685a	2026-06-23	Warnings, Adverse reactions	Exact identifier ndc (package): 62332-392-30 ndc (package): 62332-392-91 ndc (product): 62332-392 ndc11 (package): 62332039291 ndc11 (package): 62332039290 ndc11 (package): 62332039230 rxcui: 1488574
Dapagliflozin	DAPAGLIFLOZIN	Zydus Pharmaceuticals USA Inc.	17586ec6-0104-4b08-ad87-12a837568d6c	2026-06-22	Warnings, Adverse reactions	Exact identifier ndc (package): 70710-1380-3 ndc (package): 70710-1380-9 ndc (product): 70710-1380 ndc11 (package): 70710138009 ndc11 (package): 70710138003 rxcui: 1488574
DAPAGLIFLOZIN	DAPAGLIFLOZIN	Cipla USA Inc.	a2f86c0a-ce78-4d06-b5d8-ed457c8e3614	2026-06-22	Warnings, Adverse reactions	Exact identifier ndc (package): 69097-388-02 ndc (product): 69097-388 ndc11 (package): 69097038802
Dapagliflozin	DAPAGLIFLOZIN	Novadoz Pharmaceuticals LLC	107b4d25-4764-42b7-80e3-9aaff20865ed	2026-06-17	Warnings, Adverse reactions	Exact identifier ndc (package): 72205-432-02 ndc (package): 72205-432-03 ndc (package): 72205-432-01 ndc (product): 72205-432 ndc11 (package): 72205043203 ndc11 (package): 72205043202 ndc11 (package): 72205043201 rxcui: 1488574
DAPAGLIFLOZIN	DAPAGLIFLOZIN	Prasco Laboratories	3aba33aa-f8c6-4b10-85c8-dfa14578d07c	2026-06-03	Warnings, Adverse reactions	Exact identifier ndc (package): 66993-456-30 ndc (product): 66993-456 ndc11 (package): 66993045630 rxcui: 1488574
FARXIGA	DAPAGLIFLOZIN	AstraZeneca Pharmaceuticals LP	72ad22ae-efe6-4cd6-a302-98aaee423d69	2026-06-03	Warnings, Adverse reactions	Exact identifier rxcui: 1488574
Dapagliflozin	DAPAGLIFLOZIN	AvKARE	52a778e7-6044-2049-e063-6294a90aa0b7	2026-05-27	Warnings, Adverse reactions	Exact identifier ndc (package): 73190-072-90 ndc (package): 73190-072-30 ndc (product): 73190-072 ndc11 (package): 73190007230 ndc11 (package): 73190007290 rxcui: 1488574
Dapagliflozin	DAPAGLIFLOZIN	A-S Medication Solutions	c4264ff6-5199-49e9-91d3-3ad67b42f88d	2026-05-18	Warnings, Adverse reactions	Exact identifier ndc (package): 50090-7971-0 ndc (product): 50090-7971 ndc11 (package): 50090797100 rxcui: 1488574
FARXIGA	DAPAGLIFLOZIN	REMEDYREPACK INC.	ef9e9c8c-5460-4193-952a-0c249dd071bd	2026-04-24	Warnings, Adverse reactions	Exact identifier rxcui: 1488574
DAPAGLIFLOZIN	DAPAGLIFLOZIN	Alembic Pharmaceuticals Limited	d44f7eed-dd51-40d1-8408-8fb331e1f1f6	2026-04-21	Warnings, Adverse reactions	Exact identifier ndc (package): 46708-392-91 ndc (package): 46708-392-30 ndc (product): 46708-392 ndc11 (package): 46708039230 ndc11 (package): 46708039290 ndc11 (package): 46708039291 rxcui: 1488574
Dapagliflozin	DAPAGLIFLOZIN	Apotex Corp.	bd9766c5-104f-4636-897d-b6c92eb94f18	2026-04-10	Warnings, Adverse reactions	Exact identifier ndc (package): 60505-4911-3 ndc (product): 60505-4911 ndc11 (package): 60505491103 rxcui: 1488574
Dapagliflozin	DAPAGLIFLOZIN	Zydus Lifesciences Limited	db668c5c-2d49-41c8-8ffd-c2b2652b621a	2026-04-06		Exact identifier ndc (package): 70771-1714-3 ndc (package): 70771-1714-9 ndc (product): 70771-1714 ndc11 (package): 70771171409 ndc11 (package): 70771171403 rxcui: 1488574
Dapagliflozin	DAPAGLIFLOZIN	Lupin Pharmaceuticals, Inc.	08baca21-e39e-4e61-961f-d89432fe8007	2026-04-02	Warnings, Adverse reactions	Exact identifier ndc (package): 70748-105-06 ndc (product): 70748-105 ndc11 (package): 70748010506 rxcui: 1488574

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 25 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
72ad22ae-efe6-4cd6-a302-98aaee423d69	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	45	These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA ® (dapagliflozin) tablets, for oral use Initial U.S. Approval: 2014	20241024
40cc4f5d-bcf6-4016-9d1e-838bbc4bdddc	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	20	These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA ® (dapagliflozin) tablets, for oral use Initial U.S. Approval: 2014	20240829
01f90c94-71cb-4a1f-81ff-8004b850529b	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	15	These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA ® (dapagliflozin) tablets, for oral use Initial U.S. Approval: 2014	20231212
08baca21-e39e-4e61-961f-d89432fe8007	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	14	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260402
828f1004-3647-9a13-8008-c4b3759ecfd0	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	12	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260212
840e2146-2383-489b-bcc4-fecfe986685a	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	11	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260407
f615d81e-d1e8-4561-a4d9-286c615d3bd2	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	10	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20250811
b6b8a10c-64c3-4856-8961-d72d68784f5d	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	9	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260320
3aba33aa-f8c6-4b10-85c8-dfa14578d07c	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	9	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20241024
db668c5c-2d49-41c8-8ffd-c2b2652b621a	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	6	Dapagliflozin Tablets	20260406
a2f86c0a-ce78-4d06-b5d8-ed457c8e3614	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	5	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260408
0406a1c0-56b1-4ea1-95ae-00357ac1ba7e	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	5	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20251031
82cdd5ad-df2b-4bdd-a3a6-a059040100b4	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	4	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20240628
20a83ea2-6ad8-4bbb-b516-73c0a9e37399	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	3	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260428
17586ec6-0104-4b08-ad87-12a837568d6c	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	3	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260406
52a778e7-6044-2049-e063-6294a90aa0b7	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	2	DAPAGLIFLOZIN tablets, for oral use These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. Initial U.S. Approval: 2014	20260527
f56593f7-588e-489d-9fad-b459e90dab18	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260511
bd9766c5-104f-4636-897d-b6c92eb94f18	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260410
107b4d25-4764-42b7-80e3-9aaff20865ed	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260408
91373924-66dc-4277-aaf2-8536e81a0e4d	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260407
c4264ff6-5199-49e9-91d3-3ad67b42f88d	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260518
6425d240-5dd9-4a2c-9348-f8a859702850	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260513
ef9e9c8c-5460-4193-952a-0c249dd071bd	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA ® (dapagliflozin) tablets, for oral use Initial U.S. Approval: 2014	20260424
d44f7eed-dd51-40d1-8408-8fb331e1f1f6	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260407
8296f538-4c23-4d6c-be53-8005b83c24b7	dapagliflozin 5 MG Oral Tablet [PSN] · dapagliflozin 5 MG Oral Tablet [SCD] · dapagliflozin 5 MG Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260331

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
8296f538-4c23-4d6c-be53-8005b83c24b7	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Sandoz Inc	20260730
f56593f7-588e-489d-9fad-b459e90dab18	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Aurobindo Pharma Limited \| APL HEALTHCARE LIMITED	20260717
f56593f7-588e-489d-9fad-b459e90dab18	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Aurobindo Pharma Limited \| APL HEALTHCARE LIMITED	20260716
91373924-66dc-4277-aaf2-8536e81a0e4d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Macleods Pharmaceuticals Limited	20260709
20a83ea2-6ad8-4bbb-b516-73c0a9e37399	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Florida Pharmaceutical Products, LLC \| Inventia Healthcare Limited. \| Inventia Healthcare Limited	20260702
6425d240-5dd9-4a2c-9348-f8a859702850	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	ANI Pharmaceuticals, Inc.	20260629
b6b8a10c-64c3-4856-8961-d72d68784f5d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Ascend Laboratories, LLC \| Alkem Laboratories Limited	20260625
840e2146-2383-489b-bcc4-fecfe986685a	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Alembic Pharmaceuticals Inc. \| Alembic Pharmaceuticals Limited	20260623
a2f86c0a-ce78-4d06-b5d8-ed457c8e3614	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets USP, for oral use Initial U.S. Approval: 2014	Cipla USA Inc. \| Cipla Limited \| MSN Laboratories Private Limited \| CIPLA LIMITED GOA	20260622
17586ec6-0104-4b08-ad87-12a837568d6c	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Zydus Pharmaceuticals USA Inc. \| Zydus Lifesciences Limited	20260622
107b4d25-4764-42b7-80e3-9aaff20865ed	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Novadoz Pharmaceuticals LLC \| MSN LABORATORIES PRIVATE LIMITED \| MSN Pharmaceuticals Inc.	20260617
b6b8a10c-64c3-4856-8961-d72d68784f5d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Ascend Laboratories, LLC \| Alkem Laboratories Limited	20260616
91373924-66dc-4277-aaf2-8536e81a0e4d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Macleods Pharmaceuticals Limited	20260608
3aba33aa-f8c6-4b10-85c8-dfa14578d07c	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Prasco Laboratories \| AstraZeneca PLC	20260603
3aba33aa-f8c6-4b10-85c8-dfa14578d07c	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Prasco Laboratories \| AstraZeneca PLC	20260603
52a778e7-6044-2049-e063-6294a90aa0b7	DAPAGLIFLOZIN tablets, for oral use These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. Initial U.S. Approval: 2014	AvKARE	20260527
52a778e7-6044-2049-e063-6294a90aa0b7	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	AvKARE	20260525
c4264ff6-5199-49e9-91d3-3ad67b42f88d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	A-S Medication Solutions	20260518
6425d240-5dd9-4a2c-9348-f8a859702850	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	ANI Pharmaceuticals, Inc.	20260513
f56593f7-588e-489d-9fad-b459e90dab18	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Aurobindo Pharma Limited \| APL HEALTHCARE LIMITED	20260511
20a83ea2-6ad8-4bbb-b516-73c0a9e37399	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Florida Pharmaceutical Products, LLC \| Inventia Healthcare Limited. \| Inventia Healthcare Limited	20260428
840e2146-2383-489b-bcc4-fecfe986685a	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Alembic Pharmaceuticals Inc. \| Alembic Pharmaceuticals Limited	20260422
d44f7eed-dd51-40d1-8408-8fb331e1f1f6	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Alembic Pharmaceuticals Limited	20260421
bd9766c5-104f-4636-897d-b6c92eb94f18	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Apotex Corp. \| Aizant Drug Research Solutions Pvt Ltd	20260410
a2f86c0a-ce78-4d06-b5d8-ed457c8e3614	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Cipla USA Inc. \| Cipla Limited \| MSN Laboratories Private Limited \| CIPLA LIMITED GOA	20260408
107b4d25-4764-42b7-80e3-9aaff20865ed	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Novadoz Pharmaceuticals LLC \| MSN LABORATORIES PRIVATE LIMITED	20260408
107b4d25-4764-42b7-80e3-9aaff20865ed	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Novadoz Pharmaceuticals LLC \| MSN LABORATORIES PRIVATE LIMITED	20260408
840e2146-2383-489b-bcc4-fecfe986685a	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Alembic Pharmaceuticals Inc. \| Alembic Pharmaceuticals Limited	20260407
91373924-66dc-4277-aaf2-8536e81a0e4d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Macleods Pharmaceuticals Limited	20260407
d44f7eed-dd51-40d1-8408-8fb331e1f1f6	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Alembic Pharmaceuticals Limited	20260407
f56593f7-588e-489d-9fad-b459e90dab18	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Aurobindo Pharma Limited \| APL HEALTHCARE LIMITED	20260407
db668c5c-2d49-41c8-8ffd-c2b2652b621a	Dapagliflozin Tablets	Zydus Lifesciences Limited	20260406
17586ec6-0104-4b08-ad87-12a837568d6c	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Zydus Pharmaceuticals USA Inc. \| Zydus Lifesciences Limited	20260406
a2f86c0a-ce78-4d06-b5d8-ed457c8e3614	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Cipla USA Inc. \| Cipla Limited \| MSN Laboratories Private Limited \| CIPLA LIMITED GOA	20260404
08baca21-e39e-4e61-961f-d89432fe8007	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	20260402
8296f538-4c23-4d6c-be53-8005b83c24b7	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Sandoz Inc	20260331
b6b8a10c-64c3-4856-8961-d72d68784f5d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Ascend Laboratories, LLC \| Alkem Laboratories Limited	20260320
828f1004-3647-9a13-8008-c4b3759ecfd0	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Biocon Pharma Inc. \| Biocon Pharma Limited \| Biocon Limited \| Syngene International Limited	20260212
0406a1c0-56b1-4ea1-95ae-00357ac1ba7e	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Teva Pharmaceuticals, Inc.	20251031
0406a1c0-56b1-4ea1-95ae-00357ac1ba7e	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Teva Pharmaceuticals, Inc.	20251031

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	A10BK	Sodium-glucose co-transporter 2 (SGLT2) inhibitors	ATC1-4		dapagliflozin
FDASPL	N0000187059	Sodium-Glucose Cotransporter 2 Inhibitor	EPC	has_epc	dapagliflozin
FDASPL	N0000187058	Sodium-Glucose Transporter 2 Inhibitors	MOA	has_moa	dapagliflozin
MEDRT	D001559	Benzhydryl Compounds	CHEM	has_ingredient	dapagliflozin
MEDRT	D005960	Glucosides	CHEM	has_ingredient	dapagliflozin
MEDRT	D003924	Diabetes Mellitus, Type 2	DISEASE	may_treat	dapagliflozin
MEDRT	D006333	Heart Failure	DISEASE	may_treat	dapagliflozin
MEDRT	N0000187058	Sodium-Glucose Transporter 2 Inhibitors	MOA	has_moa	dapagliflozin
MEDRT	N0000175650	Decreased Sympathetic Activity	PE	has_pe	dapagliflozin
MEDRT	N0000009556	Increased Renal Organic Ion Excretion	PE	has_pe	dapagliflozin
MEDRT	N0000009830	Renal Ion Transport Alteration	PE	has_pe	dapagliflozin

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Farxiga	rxnav_allrelated
DF	DF	Oral Tablet	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
IN	IN	dapagliflozin	rxnav_allrelated
SBD	SBD	dapagliflozin 5 MG Oral Tablet [Farxiga]	rxnav_allrelated
SBDC	SBDC	dapagliflozin 5 MG [Farxiga]	rxnav_allrelated
SBDF	SBDF	dapagliflozin Oral Tablet [Farxiga]	rxnav_allrelated
SBDG	SBDG	Farxiga Oral Product	rxnav_allrelated
SBDG	SBDG	Farxiga Pill	rxnav_allrelated
SCD	SCD	dapagliflozin 5 MG Oral Tablet	rxnav_allrelated
SCDC	SCDC	dapagliflozin 5 MG	rxnav_allrelated
SCDF	SCDF	dapagliflozin Oral Tablet	rxnav_allrelated
SCDG	SCDG	dapagliflozin Oral Product	rxnav_allrelated
SCDG	SCDG	dapagliflozin Pill	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	5 MG
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	ANDA	ANDA211156
CODES	ANDA	ANDA211312
CODES	ANDA	ANDA211468
CODES	ANDA	ANDA211470
CODES	ANDA	ANDA211478
CODES	ANDA	ANDA211482
CODES	ANDA	ANDA211506
CODES	ANDA	ANDA211523
CODES	ANDA	ANDA211531
CODES	ANDA	ANDA211535
CODES	ANDA	ANDA211541
CODES	ANDA	ANDA211545
CODES	ANDA	ANDA211560
CODES	ANDA	ANDA211582
CODES	SNOMEDCT	1145542000
CODES	VUID	4033036
NAMES	Prescribable Synonym	dapagliflozin 5 MG Oral Tablet
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon
SOURCES	Source	National Drug Data File Plus Source Vocabulary
SOURCES	Source	US Edition of SNOMED_CT
SOURCES	Source	Veterans Health Administration National Drug File